Literature DB >> 2309792

Hypomelanosis of Ito--a nonspecific marker of somatic mosaicism: report of case with trisomy 18 mosaicism.

D Chitayat1, J M Friedman, M M Johnston.   

Abstract

We report on a patient with hypomelanosis of Ito (HI), developmental delay, recurrent pneumonia, and facial asymmetry. Chromosome analysis done on blood and on one of three skin biopsies showed trisomy 18 mosaicism. This is the first report of HI associated with trisomy 18 mosaicism. This neuroectodermal disorder appears to be a nonspecific manifestation of chromosome mosaicism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309792     DOI: 10.1002/ajmg.1320350320

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Authors:  W F Schwindinger; C A Francomano; M A Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 2.  Hypomelanosis of Ito and brain abnormalities: MRI findings and literature review.

Authors:  J Steiner; C Adamsbaum; I Desguerres; G Lalande; F Raynaud; G Ponsot; G Kalifa
Journal:  Pediatr Radiol       Date:  1996-11

3.  Asymmetry and skin pigmentary anomalies in chromosome mosaicism.

Authors:  C G Woods; A Bankier; J Curry; L J Sheffield; S F Slaney; K Smith; L Voullaire; D Wellesley
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

Review 4.  Pigmentary mosaicism: a review of original literature and recommendations for future handling.

Authors:  Anna Boye Kromann; Lilian Bomme Ousager; Inas Kamal Mohammad Ali; Nurcan Aydemir; Anette Bygum
Journal:  Orphanet J Rare Dis       Date:  2018-03-05       Impact factor: 4.123

5.  Pallister-Killian syndrome: clinical, cytogenetic and molecular findings in 15 cases.

Authors:  Birsen Karaman; Hülya Kayserili; Asadollah Ghanbari; Zehra Oya Uyguner; Güven Toksoy; Umut Altunoglu; Seher Basaran
Journal:  Mol Cytogenet       Date:  2018-08-17       Impact factor: 2.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.